Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Cerus (CERS) Q3 2026 Earnings Call Transcript

REDeS trial met efficacy endpoints; ISC revenue surged 44% year over year.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at fool.com →

More in Finance & Markets

More from Tuesday 3 November →